Innovative Technologies for Molecular Analysis of Cancer (R21)

The summary for the Innovative Technologies for Molecular Analysis of Cancer (R21) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Innovative Technologies for Molecular Analysis of Cancer (R21): -Purpose. This Funding Opportunity Announcement (FOA) issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), solicits grant applications proposing exploratory research projects focused on the inception and early stage development of highly innovative cancer-relevant technologies. The emphasis of this FOA is on technically innovative molecular analysis tools with the potential to add a new quality to the investigations of the molecular basis of cancer (e.g., by facilitating the detection of cancer-related characteristics/alterations at the molecular and cellular levels of organization and function). These technologies may be intended for molecular analyses in vitro, in situ, and/or in vivo. Responsive technologies encompass relevant methods, techniques, tools, instrumentation, and devices (but not software or informatics solutions). This funding opportunity is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program. Several IMAT FOAs of identical or closely related scientific scope using various funding mechanisms are available. To facilitate selection, a separate Notice in the NIH Guide for Grants and Contracts provides brief cross-comparison and links to all the IMAT FOAs. See NOT-CA-08-003. -Mechanism of Support. This FOA will utilize the NIH R21 award mechanism for exploratory (pilot) research projects. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. -Funds Available and Anticipated Number of Awards. The NCI intends to commit a total of approximately $3,000,000 to this FOA in fiscal year 2009 to award approximately 10 to 15 grants.